share_log

Harrow Health Analyst Ratings

Benzinga ·  Jul 20, 2023 22:21
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
07/20/2023 106.99% B. Riley Securities $42 → $45 Maintains Buy
04/17/2023 70.19% Lake Street $24 → $37 Maintains Buy
09/08/2022 -21.8% B. Riley Securities → $17 Reinstates → Buy
05/20/2022 -8% B. Riley Securities $17 → $20 Maintains Buy
07/02/2021 -34.45% Ladenburg Thalmann → $14.25 Initiates Coverage On → Buy
04/07/2020 -54% B. Riley Securities $12 → $10 Maintains Buy
03/16/2020 -44.8% B. Riley Securities $12.75 → $12 Maintains Buy

What is the target price for Harrow Health (HROW)?

The latest price target for Harrow Health (NASDAQ: HROW) was reported by B. Riley Securities on July 20, 2023. The analyst firm set a price target for $45.00 expecting HROW to rise to within 12 months (a possible 106.99% upside). 3 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Harrow Health (HROW)?

The latest analyst rating for Harrow Health (NASDAQ: HROW) was provided by B. Riley Securities, and Harrow Health maintained their buy rating.

When is the next analyst rating going to be posted or updated for Harrow Health (HROW)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Harrow Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Harrow Health was filed on July 20, 2023 so you should expect the next rating to be made available sometime around July 20, 2024.

Is the Analyst Rating Harrow Health (HROW) correct?

While ratings are subjective and will change, the latest Harrow Health (HROW) rating was a maintained with a price target of $42.00 to $45.00. The current price Harrow Health (HROW) is trading at is $21.74, which is out of the analyst's predicted range.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment